首页> 美国卫生研究院文献>other >A non-transformed oligodendrocyte precursor cell line OL-1 facilitates studies of insulin-like growth factor-I signaling during oligodendrocyte development
【2h】

A non-transformed oligodendrocyte precursor cell line OL-1 facilitates studies of insulin-like growth factor-I signaling during oligodendrocyte development

机译:非转化的少突胶质细胞前体细胞系OL-1有助于少突胶质细胞发育过程中胰岛素样生长因子-I信号的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The process by which oligodendrocyte progenitors differentiate into mature oligodendrocytes is complex and incompletely understood in part because of the paucity of oligodendrocyte precursors cell lines that can be studied in culture. We have developed a non-immortalized rat oligodendrocyte precursor line, called OL-1, which behaves in a fashion consistent with developing oligodendrocytes in vivo. This OL-1 line provides a model for the study of oligodendrocyte development and offers an alternative to the CG-4 cell line. When OL-1 cells are propagated in conditioned growth media, they have morphology consistent with immature oligodendrocytes and exhibit A2B5 antigen positive and myelin basic protein-negative immunoreactivity. Withdrawal of conditioned growth media and culture in serum-free medium results in OL-1 cell maturation, manifested by a shift to myelin basic protein-positive immunoreactivity, A2B5 antigen-negative immunoreactivity, decreased NG2 mRNA expression, increased expression of proteolipid protein mRNA, and increased expression of CNP protein. In addition, the expression of proteolipid protein and its splicing variant DM-20 exhibit a pattern that is similar to brain proteolipid protein expression during development. When OL-1 cells are exposed to Insulin-like growth factor-I, there are significant increases in proteolipid protein mRNA expression ( p < 0.05), the number of cell processes ( p < 0.05), and cell number ( p < 0.05). Treatment with the caspase inhibitors Z-DEVD-FMK and Z-VAD-FMK (inhibitors of caspases 3, 6, 7, 8, 10 and 1, 3, 4, respectively), Insulin-like growth factor-I, or both, results in a similar increase in cell number. Because Insulin-like growth factor-I does not substantially increase the BrdU labeling of OL-1 cells, these data collectively indicate that Insulin-like growth factor-I increases OL-1 cell number predominately by promoting survival, rather than stimulating proliferation. This non-immortalized oligodendrocyte precursor cell line, therefore, exhibits behavior consistent with the in vivo development of oligodendrocytes and provides an excellent model for the study of developing oligodendrocytes.
机译:少突胶质细胞祖细胞分化成成熟少突胶质细胞的过程是复杂且不完全了解的,部分原因是可以在培养中研究的少突胶质细胞前体细胞系。我们已经开发了一种称为OL-1的永生化大鼠少突胶质细胞前体细胞,其行为方式与体内体内少突胶质细胞的发育一致。该OL-1系为研究少突胶质细胞的发展提供了模型,并为CG-4细胞系提供了替代方案。当OL-1细胞在条件生长培养基中繁殖时,它们的形态与不成熟的少突胶质细胞一致,并表现出A2B5抗原阳性和髓磷脂碱性蛋白阴性的免疫反应性。撤回条件生长培养基和在无血清培养基中培养会导致OL-1细胞成熟,表现为转变为髓磷脂碱性蛋白阳性免疫反应性,A2B5抗原阴性免疫反应性,NG2 mRNA表达降低,蛋白脂蛋白mRNA表达增加,和增加CNP蛋白的表达。此外,蛋白脂蛋白及其剪接变体DM-20的表达与发育过程中脑蛋白脂蛋白的表达相似。当OL-1细胞暴露于胰岛素样生长因子I时,脂蛋白mRNA表达(p <0.05),细胞进程数(p <0.05)和细胞数(p <0.05)显着增加。 。使用半胱天冬酶抑制剂Z-DEVD-FMK和Z-VAD-FMK(分别是胱天蛋白酶3、6、7、8、10和1、3、4的抑制剂),胰岛素样生长因子-I或两者进行治疗,导致细胞数量的类似增加。由于胰岛素样生长因子-1基本上不增加OL-1细胞的BrdU标记,因此这些数据共同表明,胰岛素样生长因子-1主要通过促进存活而不是刺激增殖来增加OL-1细胞数量。因此,这种永生化的少突胶质细胞前体细胞系表现出与少突胶质细胞的体内发育一致的行为,并为研究少突胶质细胞的发展提供了极好的模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号